As of 2026-01-20, the Relative Valuation of Paratek Pharmaceuticals Inc (PRTK) is (17.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.23 USD, the upside of Paratek Pharmaceuticals Inc based on Relative Valuation is -877.9%.
The range of the Relative Valuation is (11.82) - (17.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 16.3x | 14.5x |
| Forward P/E multiples | 10.8x - 19.0x | 17.2x |
| Fair Price | (11.82) - (17.86) | (17.35) |
| Upside | -630.0% - -900.9% | -877.9% |
| Date | P/E |